Clomiphene citrate, metformin or a combination of both as the first line ovulation induction drug for Asian Indian women with polycystic ovarian syndrome: A randomized controlled trial
Aim: To compare clomiphene citrate (CC), metformin or the combination of CC and metformin as the first line ovulation induction drug in Asian Indian women with polycystic ovary syndrome (PCOS). Methods: One hundred and five newly diagnosed, treatment naive PCOS women were recruited. They were random...
Saved in:
Main Authors: | , |
---|---|
Format: | Book |
Published: |
Wolters Kluwer Medknow Publications,
2015-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
LEADER | 00000 am a22000003u 4500 | ||
---|---|---|---|
001 | doaj_6b8b42d9f6ee46ee859c304814a1cbbd | ||
042 | |a dc | ||
100 | 1 | 0 | |a Sujata Kar |e author |
700 | 1 | 0 | |a Smriti Sanchita |e author |
245 | 0 | 0 | |a Clomiphene citrate, metformin or a combination of both as the first line ovulation induction drug for Asian Indian women with polycystic ovarian syndrome: A randomized controlled trial |
260 | |b Wolters Kluwer Medknow Publications, |c 2015-01-01T00:00:00Z. | ||
500 | |a 0974-1208 | ||
500 | |a 1998-4766 | ||
500 | |a 10.4103/0974-1208.170373 | ||
520 | |a Aim: To compare clomiphene citrate (CC), metformin or the combination of CC and metformin as the first line ovulation induction drug in Asian Indian women with polycystic ovary syndrome (PCOS). Methods: One hundred and five newly diagnosed, treatment naive PCOS women were recruited. They were randomized into any of the three groups: Group I (CC 50-150 mg/day), Group II (metformin 1700 mg/day), and Group III (CC + metformin in similar dosage to Groups I and II). Patients underwent follicular monitoring and advice on timed intercourse. The study period was 6 months, or till pregnant, or till CC resistant. Primary outcome studied was live birth rate (LBR). Secondary outcomes were ovulation rate, pregnancy rate, and early pregnancy loss rate. Results: There was no significant difference among the groups in baseline characteristics and biochemical parameters. LBR was 41.6%, 37.5%, and 28.1%, respectively in Groups III, II, and I. Group III (CC + metformin) had the highest ovulation (83.3%), pregnancy (50%), and LBRs (41.6%). Group II (metformin) was as good as Group I (CC) in all the outcomes. CC + metformin (Group III) had statistically significantly higher ovulation rate as compared to CC alone (Group I) (P = 0.03; odds ratio: 95% confidence interval: 3.888 [1.08-13.997]). Conclusion: Thus, our study shows that metformin was as good as CC in terms of "LBR" and the combination of CC and metformin gave the highest ovulation and LBR. | ||
546 | |a EN | ||
690 | |a Clomiphene citrate | ||
690 | |a metformin | ||
690 | |a ovulation induction | ||
690 | |a polycystic ovary syndrome | ||
690 | |a pregnancy rate | ||
690 | |a Gynecology and obstetrics | ||
690 | |a RG1-991 | ||
655 | 7 | |a article |2 local | |
786 | 0 | |n Journal of Human Reproductive Sciences, Vol 8, Iss 4, Pp 197-201 (2015) | |
787 | 0 | |n http://www.jhrsonline.org/article.asp?issn=0974-1208;year=2015;volume=8;issue=4;spage=197;epage=201;aulast=Kar | |
787 | 0 | |n https://doaj.org/toc/0974-1208 | |
787 | 0 | |n https://doaj.org/toc/1998-4766 | |
856 | 4 | 1 | |u https://doaj.org/article/6b8b42d9f6ee46ee859c304814a1cbbd |z Connect to this object online. |